Cargando…
Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier
Despite significant advances in developing drugs to treat brain tumours, achieving therapeutic concentrations of the drug at the tumour site remains a major challenge due to the presence of the blood–brain barrier (BBB). Several strategies have evolved to enhance brain delivery of chemotherapeutic a...
Autores principales: | Barzegar-Fallah, Anita, Gandhi, Kushan, Rizwan, Shakila B., Slatter, Tania L., Reynolds, John N. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607160/ https://www.ncbi.nlm.nih.gov/pubmed/36297666 http://dx.doi.org/10.3390/pharmaceutics14102231 |
Ejemplares similares
-
Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies
por: Gandhi, Kushan, et al.
Publicado: (2022) -
Correction: Gandhi et al. Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies. Pharmaceutics 2022, 14, 833
por: Gandhi, Kushan, et al.
Publicado: (2022) -
Inducible and reversible breaching of the blood brain barrier by RNAi
por: Rossi, John J
Publicado: (2011) -
Breaching the Blood–Brain Tumor Barrier for Tumor Therapy
por: Marcucci, Fabrizio, et al.
Publicado: (2021) -
Breaching the Blood-Brain Barrier as a Gate to Psychiatric Disorder
por: Shalev, Hadar, et al.
Publicado: (2009)